Buscar
CorMedix Inc
CRMDAñadir a la lista de seguimiento
8.750USD
+0.280+3.31%
Cierre 07/02, 13:00（ET）Cotizaciones retrasadas 15 min
686.45MCap. mercado
3.60P/E TTM
Más Datos de CorMedix Inc Compañía
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
Información de CorMedix Inc
Símbolo de cotizaciónCRMD
Nombre de la empresaCorMedix Inc
Fecha de salida a bolsaMar 25, 2010
Director ejecutivoTodisco (Joseph)
Número de empleados64
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 25
Dirección300 Connell Drive
CiudadBERKELEY HEIGHTS
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07922
Teléfono19085179500
Sitio Webhttps://cormedix.com/
Símbolo de cotizaciónCRMD
Fecha de salida a bolsaMar 25, 2010
Director ejecutivoTodisco (Joseph)
Ejecutivos de CorMedix Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
401.08K
-41.48%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+47.50%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
38.47K
-14.17%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
38.33K
-14.23%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
36.00K
-15.15%
Mr. Myron M. Kaplan, J.D.
Mr. Myron M. Kaplan, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
Ms. Elizabeth (Liz) Massonhurlburt
Ms. Elizabeth (Liz) Massonhurlburt
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Matthew T. (Matt) David, M.D.
Dr. Matthew T. (Matt) David, M.D.
Chief Business Officer
Chief Business Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joseph (Joe) Todisco
Mr. Joseph (Joe) Todisco
Chief Executive Officer, Director
Chief Executive Officer, Director
401.08K
-41.48%
Ms. Susan Blum
Ms. Susan Blum
Chief Financial Officer
Chief Financial Officer
132.74K
+47.50%
Mr. Steven W. Lefkowitz
Mr. Steven W. Lefkowitz
Independent Director
Independent Director
127.65K
-4.27%
Ms. Janet M. Dillione
Ms. Janet M. Dillione
Independent Director
Independent Director
38.47K
-14.17%
Mr. Gregory Scott (Greg) Duncan
Mr. Gregory Scott (Greg) Duncan
Independent Director
Independent Director
38.33K
-14.23%
Mr. Robert Stewart
Mr. Robert Stewart
Independent Director
Independent Director
36.00K
-15.15%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de CorMedix Inc?
Los cinco principales accionistas de CorMedix Inc son: Mr. Joseph (Joe) Todisco
¿Cuántas instituciones poseen acciones de CorMedix Inc (CRMD)?
A fecha de 2026Q1, 390 instituciones poseen acciones de CorMedix Inc, con un valor de mercado combinado de aproximadamente 43.28M, lo que representa el 55.17% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -18630389.00.